Table 2. Studies evaluating rate of exudation in eyes with subclinical CNV.
Study | Eyes with Subclinical CNV | Eyes Progressed to Exudative AMD | Follow up period |
---|---|---|---|
Dias et al. (2017) | 23 | 5 (21.7%) | 12 months |
Capuano et al. (2017) | 19 (GA only) | 5 (26.3%) | 6 months |
Carnevali et al. (2018) | 15 | 1 (6.67%) | 12 months |
Yanagi et al. (2018) | 18 (includes PCV) | 4 (estimated 18.1% annually) | >6 months |
Our study | 5 | 1 (20.0%) | 12 months |